LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

Search

Stryker Corp

Deschisă

Sector Sănătate

371.86 0.49

Rezumat

Modificarea prețului

24h

Curent

Minim

369.56

Maxim

374

Indicatori cheie

By Trading Economics

Venit

37M

825M

Vânzări

200M

5.4B

P/E

Medie Sector

38.84

103.001

EPS

2.81

Marjă de profit

15.278

Angajați

52,000

EBITDA

77M

1.3B

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+2.78 upside

Dividende

By Dow Jones

Următoarele câștiguri

31 oct. 2024

Data viitoare de dividende

31 oct. 2024

Următoarea dată ex-dividende

30 sept. 2024

Statistici piață

By TradingEconomics

Capitalizare de piață

137B

Deschiderea anterioară

371.37

Închiderea anterioară

371.86

Sentimentul știrilor

By Acuity

50%

50%

97 / 365 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bullish Evidence

Stryker Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

22 aug. 2024, 12:39 UTC

Achiziții, Fuziuni, Preluări

Stryker to Buy Pain-Management Company Vertos Medical

30 iul. 2024, 20:46 UTC

Câștiguri

Stryker Raises Fiscal Year Guidance on Sales Momentum, Healthy Demand

30 apr. 2024, 20:34 UTC

Câștiguri

Stryker Lifts Organic Sales Outlook After 1Q Rise

22 aug. 2024, 12:06 UTC

Achiziții, Fuziuni, Preluări

Stryker And Vertos Medical Will Continue to Operate as Separate Entities Until Deal Closes >SYK

22 aug. 2024, 12:00 UTC

Achiziții, Fuziuni, Preluări

Stryker to Acquire Vertos Medical >SYK

22 aug. 2024, 12:00 UTC

Achiziții, Fuziuni, Preluări

Stryker Announces Definitive Agreement To Acquire Vertos Medical, Inc., Expanding Interventional Pain Management Solutions >SYK

12 aug. 2024, 12:00 UTC

Achiziții, Fuziuni, Preluări

Stryker: Acquisition Will Strengthen Growing Healthcare IT Offering >SYK

12 aug. 2024, 12:00 UTC

Achiziții, Fuziuni, Preluări

Stryker Announces Definitive Agreement To Acquire Care.Ai, A Leading Virtual Care And Ambient Intelligence Solutions Platform >SYK

31 iul. 2024, 12:45 UTC

Achiziții, Fuziuni, Preluări

Stryker Completes Acquisition of MOLLI Surgical >SYK

31 iul. 2024, 12:45 UTC

Achiziții, Fuziuni, Preluări

Stryker Completes Acquisition Of MOLLI Surgical >SYK

30 iul. 2024, 20:31 UTC

Câștiguri

Stryker Raises FY Guidance on Sales Momentum, Healthy Demand

30 iul. 2024, 20:07 UTC

Câștiguri

Stryker: Now Expect Full Yr 2024 Organic Net Sales Growth in Range of 9.0% to 10.0% With a Favorable Pricing Impact of Approximately 0.5% >SYK

30 iul. 2024, 20:05 UTC

Câștiguri

Stryker 2Q Net $825M >SYK

30 iul. 2024, 20:05 UTC

Câștiguri

Stryker 2Q EPS $2.14 >SYK

30 iul. 2024, 20:05 UTC

Câștiguri

Stryker 2Q Net $825M >SYK

30 iul. 2024, 20:05 UTC

Câștiguri

Stryker 2Q Adj EPS $2.81 >SYK

30 iul. 2024, 20:05 UTC

Câștiguri

Stryker 2Q Net $825M >SYK

30 iul. 2024, 20:05 UTC

Câștiguri

Stryker 2Q EPS $2.14 >SYK

30 iul. 2024, 20:05 UTC

Câștiguri

Stryker Sees FY Adj EPS $11.90-Adj EPS $12.10 >SYK

30 iul. 2024, 20:05 UTC

Câștiguri

Stryker 2Q Sales $5.4B >SYK

15 iul. 2024, 12:00 UTC

Achiziții, Fuziuni, Preluări

Stryker Completes Acquisition Of Artelon, Inc. >SYK

3 iun. 2024, 12:01 UTC

Achiziții, Fuziuni, Preluări

Stryker: Artelon Offers Soft Tissue Fixation Solutions for Orthopaedic Surgeons >SYK

3 iun. 2024, 12:00 UTC

Achiziții, Fuziuni, Preluări

Stryker Announces Definitive Agreement To Acquire Artelon, Inc., Offering A Range Of Soft Tissue Fixation Solutions For Orthopaedic Surgeons >SYK

30 apr. 2024, 20:57 UTC

Câștiguri

Stryker Skids As Light Knee Replacements Weigh On Beat-And-Raise -- IBD

30 apr. 2024, 20:16 UTC

Câștiguri

Stryker Edges Higher After Issuing A Beat-And-Raise For Its First Quarter -- IBD

30 apr. 2024, 20:09 UTC

Câștiguri

Stryker Sees FY24 Adj EPS $11.85-Adj EPS $12.05 >SYK

30 apr. 2024, 20:09 UTC

Câștiguri

Stryker Sees FY24 Organic Net Sales Growth 8.5% to 9.5% With Pricing Impact Roughly Flat >SYK

30 apr. 2024, 20:05 UTC

Câștiguri

Stryker 1Q Net $788M >SYK

30 apr. 2024, 20:05 UTC

Câștiguri

Stryker 1Q EPS $2.05 >SYK

30 apr. 2024, 20:05 UTC

Câștiguri

Stryker 1Q Adj EPS $2.50 >SYK

Comparație

Modificare preț

Stryker Corp Așteptări

Obiectiv de preț

By TipRanks

2.78% sus

Prognoză pe 12 luni

Medie 380.56 USD  2.78%

Maxim 405 USD

Minim 345 USD

În baza a 19 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruStryker Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

19 ratings

15

Cumpărare

4

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

360.42 / N/ASuport & Rezistență

Termen scurt

Bullish Evidence

Termen mediu

Bullish Evidence

Termen lung

Bullish Evidence

Sentiment

By Acuity

97 / 365 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

EBITDA

Profit operațional

$

Despre Stryker Corp

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. Its segments include Orthopaedics, MedSurg, Neurotechnology and Spine. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products. The MedSurg segment includes surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment, intensive care disposable products; reprocessed and remanufactured medical devices, and other related products. The Neurotechnology and Spine segment includes neurovascular products, spinal implant systems and other related products. Its products include implants, which are used in joint replacement and trauma surgeries, and other products. It offers musculoskeletal care and sensor technology for total joint replacement.